Skip to main content

Recent Articles

FDA Approvals
FDA Authorizes Updated COVID-19 Vaccine Formulations for Better Protection Against Current Variants
Read More
Original Research, Clinical
Changes in Antipsychotic Medication Use Among Medicare Patients in a Nursing Home, 2010 to 2015
Michele Berrios, CHFP; Bruce Pyenson, FSA, MAAA; Kyle Pérez, MPH; Heidi C. Waters, MBA, PhD
Read More
Clinical
The Hidden Inferno: Burn Pit Exposure in the Military and Its Potential Links to Cancer
Claire Szewczyk
Read More
FDA Approvals
FDA Approval of SYFOVRE (Pegcetacoplan) and IZERVAY (Avacincaptad Pegol) Reshapes Management of GA
Jerm Day-Storms, PhD, MWC
Read More
FDA Approvals
IMJUDO (Tremelimumab-actl) in Combination With IMFINZI (Durvalumab) Receives FDA Approval for HCC and NSCLC
Jerm Day-Storms, PhD, MWC
Read More
FDA Approvals
FDA Approvals of Brand-Name Prescription Drugs, October 4, 2022, Through August 4, 2023
Read More

Recent FDA Approvals

FDA Approvals
Fruzaqla FDA Approved for Relapsed Metastatic Colorectal Cancer
Read More
FDA Approvals
Rozlytrek Now Approved for Pediatric Patients Older Than 1 Month With Solid Tumors and NTRK Gene Fusion and in New Oral Pellet Form
Read More
FDA Approvals
FDA Authorizes Updated COVID-19 Vaccine Formulations for Better Protection Against Current Variants
Read More
FDA Approvals
Bosulif Now FDA Approved for Pediatric Patients With Chronic Myelogenous Leukemia
Read More
FDA Approvals
FDA Approved Abrysvo, First RSV Vaccine for Immunizing Pregnant Women, as Prophylaxis Against RSV Infection in Infants
Read More
FDA Approvals
Tyruko First Biosimilar for the Treatment of Relapsing Forms of Multiple Sclerosis
Read More
View the Latest Issue